Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index; none of the 14 sources its claims cite is checked for support yet.

The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold

Open access

Abstract

The fidelity and specificity of information flow within a cell is controlled by scaffolding proteins that assemble and link enzymes into signalling circuits. These circuits can be inhibited by bacterial effector proteins that post-translationally modify individual pathway components. However, there is emerging evidence that pathogens directly organize higher-order signalling networks through enzyme scaffolding, and the identity of the effectors and their mechanisms of action are poorly understood. Here we identify the enterohaemorrhagic Escherichia coli O157:H7 type III effector EspG as a regulator of endomembrane trafficking using a functional screen, and report ADP-ribosylation factor (ARF) GTPases and p21-activated kinases (PAKs) as its relevant host substrates. The 2.5 Å crystal structure of EspG in complex with ARF6 shows how EspG blocks GTPase-activating-protein-assisted GTP hydrolysis, revealing a potent mechanism of GTPase signalling inhibition at organelle membranes. In addition, the 2.8 Å crystal structure of EspG in complex with the autoinhibitory Iα3-helix of PAK2 defines a previously unknown catalytic site in EspG and provides an allosteric mechanism of kinase activation by a bacterial effector. Unexpectedly, ARF and PAKs are organized on adjacent surfaces of EspG, indicating its role as a ‘catalytic scaffold’ that effectively reprograms cellular events through the functional assembly of GTPase-kinase signalling complex.

Overview

CoChat Summary

TL;DR

The EHEC O157:H7 type III effector EspG acts as a catalytic scaffold that binds ARF GTPases and PAK kinases on adjacent surfaces, inhibiting ARF GTP hydrolysis while allosterically activating PAK2. Crystal structures of EspG–ARF6 and EspG–PAK2 Iα3 reveal how EspG reprograms membrane trafficking and kinase signalling.

Key findings

  • EspG blocked hGH exocytosis, localized to the cis-Golgi, and induced Golgi fragmentation; microinjected 10 nM EspG disrupted Golgi and recycling endosome compartments without disrupting microtubules.
  • A yeast two-hybrid screen yielded 26 positive interactions with ARF1, ARF6, PAK1, PAK2, and PAK3; EspG bound GTP-loaded ARF1/ARF6 but not GDP–ARF complexes.
  • The 2.5 Å EspG–ARF6 structure showed EspG buries 602 Ų of ARF6 surface area and blocks ARF–GAP access, completely abolishing GAP-stimulated GTP hydrolysis on lipid-anchored ARF1; the binding-deficient EspG Glu392Arg mutant had no effect.
  • The 2.8 Å EspG–PAK2 Iα3 structure showed EspG buries 684 Ų of PAK2 surface area and defines a catalytic site; EspG increased PAK2 activity (7.6 ± 2.5)-fold (n = 11), comparable to Cdc42 stimulation ((7.8 ± 3.4)-fold, n = 3), and a PAK2 probe localized to Golgi in 78 ± 5% of EspG-transfected cells.

Methods

  • Functional screen: hGH secretion assay and eGFP-tagged effector localization in host cells; yeast two-hybrid screen for EspG interactors; in vitro binding with purified recombinant proteins.
  • Structural analysis: crystallized EspG (residues 42–398) with ARF6 GTPase domain (residues 13–175) and with PAK2 Iα3-helix fragment; solved EspG–ARF6 at 2.5 Å by multiwavelength anomalous dispersion and EspG–PAK2 at 2.8 Å by molecular replacement.
  • Cellular and biochemical assays: immunofluorescence, microinjection of 10 nM protein, kinase assays using immunoprecipitated pEGFP–PAK2 from 293T lysates with 10 µM ATP and 5 µCi γ32P[ATP], and Golgi-mimetic liposome reconstitution.

Limitations

  • Stated limitations: Not stated in the paper.
  • Evident from the text: structural conclusions use truncated constructs (EspG 42–398, ARF6 13–175, PAK2 Iα3 residues 121–136), so full-length protein context is not captured.
  • Evident from the text: the new experiments are cell-based or in vitro; the paper cites prior in vivo infection studies but does not present an in vivo infection model here, and the VirA comparison is described as speculative.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/nature09593

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 0 Not valid · 10 Not checked · 50 Own results and interpretations

28 more claims

Create a free account to see all 60 claims and to verify the 14 references still open.

See all claims — free account
  • It may state two separate claims as one. 24
  • Probably not a substantial claim. 2
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Cited by

See all 120

Metadata

Authors
Selyunin, A. S., Sutton, S. E., Weigele, B. A., Reddick, L. E., Orchard, R. C., Bresson, S. M., Tomchick, D. R., & Alto, N. M.
Affiliations
The University of Texas Southwestern Medical Center (US)
Corresponding author
Alto, Neal M.
Venue
Nature
Published
2010-12-19
Volume
469
Issue
7328
Pages
107-111
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2066507447
Cited by
120
References
43
Citations by year
2024: 2 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 8 · 2018: 5 · 2017: 6 · 2016: 8 · 2015: 6 · 2014: 16 · 2013: 16 · 2012: 22
FWCI
12.21
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • Ariad Pharmaceuticals
  • National Institute of Allergy and Infectious Diseases (R01AI083359, T32AI007520)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
Escherichia coli O157:H7, type III effectors, bacterial effector proteins, ARF6, p21-activated kinase, PAK2, GTPase-activating protein, endomembrane trafficking, vesicle budding, crystal structure, enterohemorrhagic Escherichia coli, host-pathogen interaction
MeSH terms
Allosteric Regulation, Animals, Biological Transport, Cell Line, Endoplasmic Reticulum, Enzyme Activation, Golgi Apparatus, Guanosine Triphosphate, Humans, Hydrolysis, Intracellular Membranes, Models, Molecular, Protein Binding, Protein Conformation, Signal Transduction, Crystallography, X-Ray, Escherichia coli O157, Catalytic Domain, ADP-Ribosylation Factors, Two-Hybrid System Techniques, Protein Interaction Mapping, Escherichia coli Proteins, Mice, Rats, p21-Activated Kinases, Biocatalysis, Protein Unfolding

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.